Reason for request
Inclusion on the list of medicines approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this medicinal product is substantial. |
Clinical Added Value
| moderate |
BERINERT provides a moderate improvement in actual benefit (IAB III) in terms of effectiveness in managing episodes of hereditary angioedema in adults and children. |
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
teWybBfUcnnGp9Dj
Listen
